Go Pro

Oxus Acquisition (OXUS) Financials

Oxus Acquisition logo
$0.85 +0.00 (+0.01%)
As of 07/17/2026
Annual Income Statements for Oxus Acquisition

Annual Income Statements for Oxus Acquisition

This table shows Oxus Acquisition's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-0.30 -27 -27 -22
Consolidated Net Income / (Loss)
-0.30 -27 -25 -19
Net Income / (Loss) Continuing Operations
-0.30 -27 -27 -22
Total Pre-Tax Income
-0.30 -28 -25 -19
Total Operating Income
-2.89 -20 -20 -11
Total Gross Profit
0.00 -1.30 2.19 3.51
Total Revenue
0.00 30 57 62
Operating Revenue
- 30 57 62
Total Cost of Revenue
0.00 31 49 51
Operating Cost of Revenue
- 31 49 51
Total Operating Expenses
2.89 19 25 18
Selling, General & Admin Expense
2.89 19 23 15
Depreciation Expense
- - 2.32 1.84
Impairment Charge
- - 0.00 2.01
Total Other Income / (Expense), net
2.58 -7.87 -10 -14
Interest Expense
- 7.28 5.06 5.99
Other Income / (Expense), net
0.00 -0.59 -5.05 -8.03
Income Tax Expense
- -0.34 -0.13 -0.07
Basic Earnings per Share
($0.02) ($2.56) ($1.25) ($0.89)
Weighted Average Basic Shares Outstanding
21.86M 10.75M 20.31M 21.43M
Diluted Earnings per Share
- ($2.56) ($1.25) ($0.89)
Weighted Average Diluted Shares Outstanding
6.56M 10.75M 20.31M 21.43M

Quarterly Income Statements for Oxus Acquisition

This table shows Oxus Acquisition's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-6.59 -5.21 -9.65 -7.39 -4.77 -5.14 -4.19 -6.22 -4.34 -7.34 -3.51
Consolidated Net Income / (Loss)
-6.59 -6.66 -8.43 -6.30 -4.83 -5.77 -4.19 -4.60 -3.78 -6.41 -3.51
Net Income / (Loss) Continuing Operations
-6.59 -5.21 -9.65 -7.39 -4.77 -5.14 -4.19 -6.22 -4.34 -7.34 -3.51
Total Pre-Tax Income
-6.59 -7.01 -8.43 -6.28 -4.83 -5.92 -4.19 -4.59 -3.78 -6.49 -3.51
Total Operating Income
-4.42 -4.51 -6.97 -5.19 -3.62 -4.62 -2.92 -3.36 -1.92 -2.84 -2.06
Total Gross Profit
-0.48 0.56 0.24 0.42 1.27 0.25 0.90 0.51 1.04 1.06 0.84
Total Revenue
7.73 -1.32 16 10 15 -1.72 6.85 6.61 14 26 7.37
Operating Revenue
7.73 -1.32 16 10 15 -1.72 6.85 6.61 14 26 7.37
Total Cost of Revenue
8.20 -1.80 14 9.41 12 -1.14 5.95 6.67 12 22 6.53
Operating Cost of Revenue
8.20 -1.80 14 9.41 12 -1.14 5.95 6.20 12 22 6.53
Total Operating Expenses
3.95 5.07 8.22 6.01 5.36 4.87 3.82 4.15 3.42 6.53 2.90
Selling, General & Admin Expense
3.44 5.58 7.22 5.61 4.89 7.30 3.82 2.51 2.97 5.26 2.90
Total Other Income / (Expense), net
-2.16 -0.96 -2.92 -2.19 -2.42 0.16 -1.27 -2.46 -3.71 -5.30 -1.45
Interest Expense
2.17 1.74 1.46 1.10 1.21 1.30 1.26 1.23 1.86 1.64 1.45
Other Income / (Expense), net
0.00 0.78 -1.46 -1.09 -1.21 1.46 -0.01 -1.23 -1.86 -3.65 -0.00
Income Tax Expense
0.00 -0.35 - 0.01 0.00 -0.15 0.00 0.01 0.00 - 0.00
Basic Earnings per Share
($0.61) ($0.63) ($0.49) $0.29 ($0.23) ($0.24) ($0.20) $0.21 ($0.18) ($0.72) ($0.16)
Weighted Average Basic Shares Outstanding
10.73M 10.75M 17.08M 21.38M 21.38M 20.31M 21.38M 21.41M 21.46M 21.43M 21.43M
Diluted Earnings per Share
($0.61) ($0.63) ($0.49) $0.29 ($0.23) ($0.24) ($0.20) $0.21 ($0.18) ($0.72) ($0.16)
Weighted Average Diluted Shares Outstanding
10.73M 10.75M 17.08M 21.38M 21.38M 20.31M 21.38M 21.41M 21.46M 21.43M 21.43M

Annual Cash Flow Statements for Oxus Acquisition

This table details how cash moves in and out of Oxus Acquisition's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-0.44 2.47 -6.96 -0.59
Net Cash From Operating Activities
-2.11 -18 -15 -6.60
Net Cash From Continuing Operating Activities
-2.11 -18 -15 -6.60
Net Income / (Loss) Continuing Operations
-0.30 -27 -25 -19
Consolidated Net Income / (Loss)
-0.30 -27 -25 -19
Depreciation Expense
- 3.94 2.32 1.84
Amortization Expense
- 0.12 0.31 0.50
Non-Cash Adjustments To Reconcile Net Income
-2.58 2.56 0.72 1.27
Changes in Operating Assets and Liabilities, net
0.78 2.85 6.88 8.77
Net Cash From Investing Activities
0.00 -4.47 -1.91 -0.07
Net Cash From Continuing Investing Activities
0.00 -4.47 -1.91 -0.07
Purchase of Property, Plant & Equipment
- -4.47 -1.97 -0.07
Other Investing Activities, net
- 0.00 0.06 0.00
Net Cash From Financing Activities
1.66 25 10 6.08
Net Cash From Continuing Financing Activities
1.66 25 10 6.08
Repayment of Debt
0.00 -17 -0.57 -2.34
Issuance of Debt
1.66 42 11 8.41
Cash Interest Paid
- 2.91 2.64 1.04
Cash Income Taxes Paid
- 0.02 0.01 0.01

Quarterly Cash Flow Statements for Oxus Acquisition

This table details how cash moves in and out of Oxus Acquisition's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-3.74 -1.35 0.60 -5.08 -2.41 -0.07 -0.46 0.01 -0.08 -0.07 0.42
Net Cash From Operating Activities
-4.85 -1.95 -6.77 -4.23 -3.27 -0.82 -1.37 -2.20 -0.19 -2.84 -0.12
Net Cash From Continuing Operating Activities
-4.85 -1.95 -6.77 -4.22 -3.36 -0.82 -1.37 -2.20 -0.19 -2.84 -0.12
Net Income / (Loss) Continuing Operations
-6.59 -6.66 -8.43 -6.30 -4.83 -5.77 -4.19 -4.60 -3.78 -6.41 -3.51
Consolidated Net Income / (Loss)
-6.59 -6.66 -8.43 -6.30 -4.83 -5.77 -4.19 -4.60 -3.78 -6.41 -3.51
Depreciation Expense
1.00 1.00 0.99 0.42 0.45 0.46 0.48 0.47 0.45 0.43 0.39
Amortization Expense
0.03 0.09 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.27 0.00
Non-Cash Adjustments To Reconcile Net Income
0.01 2.26 1.61 -0.30 -0.07 0.68 -0.17 0.11 -0.09 1.36 0.00
Changes in Operating Assets and Liabilities, net
0.71 1.35 -1.02 1.89 1.02 3.72 2.43 1.74 3.14 1.51 3.00
Net Cash From Investing Activities
-0.66 -0.95 -0.49 -0.72 -0.50 -0.20 -0.03 -0.00 -0.03 -0.00 0.00
Net Cash From Continuing Investing Activities
-0.66 -0.95 -0.49 -0.72 -0.50 -0.20 -0.03 -0.00 -0.04 -0.00 0.00
Purchase of Property, Plant & Equipment
-0.66 -0.95 -0.55 -0.51 -0.45 -0.13 -0.03 0.02 - - 0.00
Net Cash From Financing Activities
1.77 1.54 7.85 -0.12 1.36 0.95 0.94 2.21 0.15 2.78 0.54
Net Cash From Continuing Financing Activities
1.77 1.54 7.85 -0.12 1.36 0.95 0.94 2.21 0.15 2.78 0.54
Repayment of Debt
-13 -0.32 -0.15 -0.12 -0.14 - -0.15 -0.13 -0.13 -1.93 -5.40
Issuance of Debt
15 2.00 8.00 - 1.50 1.10 1.09 2.34 0.28 4.70 5.94
Cash Interest Paid
1.35 0.37 0.65 0.91 0.75 0.32 0.24 0.79 0.05 -0.05 0.81

Annual Balance Sheets for Oxus Acquisition

This table presents Oxus Acquisition's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
177 179 66 60 53
Total Current Assets
1.44 0.92 17 12 8.06
Cash & Equivalents
1.12 0.68 7.62 0.65 0.06
Accounts Receivable
- - 1.78 1.97 2.65
Inventories, net
- - 6.95 8.05 4.58
Prepaid Expenses
0.31 0.24 0.85 1.13 0.76
Plant, Property, & Equipment, net
0.00 0.00 0.00 46 44
Total Noncurrent Assets
176 179 49 2.47 0.63
Intangible Assets
- - 0.00 0.32 0.30
Other Noncurrent Operating Assets
176 179 47 0.23 0.33
Total Liabilities & Shareholders' Equity
177 179 66 60 53
Total Liabilities
0.24 2.50 87 61 72
Total Current Liabilities
0.24 2.50 67 25 70
Short-Term Debt
0.00 1.50 48 0.00 5.69
Accounts Payable
0.00 - 11 12 16
Other Current Liabilities
- 0.16 8.43 14 48
Total Noncurrent Liabilities
0.00 0.00 20 35 1.99
Capital Lease Obligations
- - - 1.14 0.49
Noncurrent Deferred & Payable Income Tax Liabilities
- - 1.57 1.46 1.38
Other Noncurrent Operating Liabilities
- - 1.75 7.61 0.12
Total Equity & Noncontrolling Interests
1.30 -1.58 -21 -0.70 -19
Total Preferred & Common Equity
1.30 -1.58 -21 -0.70 -19
Total Common Equity
1.30 -1.58 -21 -0.70 -19
Common Stock
1.71 0.00 44 90 91
Retained Earnings
-0.41 -1.58 -65 -91 -110

Quarterly Balance Sheets for Oxus Acquisition

This table presents Oxus Acquisition's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
22 70 64 62 58 57 56 51
Total Current Assets
0.08 22 15 13 11 9.93 9.47 6.82
Cash & Equivalents
0.07 8.21 3.13 0.72 0.19 0.21 0.13 0.48
Accounts Receivable
- 4.77 2.55 2.91 1.78 2.32 2.57 1.74
Inventories, net
- 6.80 7.66 8.75 7.75 7.00 6.00 3.53
Prepaid Expenses
0.01 2.40 1.81 1.05 0.85 0.40 0.77 1.07
Plant, Property, & Equipment, net
0.00 46 46 46 45 45 44 44
Total Noncurrent Assets
22 2.19 2.38 2.42 2.55 2.57 2.50 0.62
Intangible Assets
- - 0.21 0.25 0.33 0.35 0.38 0.30
Other Noncurrent Operating Assets
22 0.27 0.26 0.25 0.31 0.30 0.20 0.32
Total Liabilities & Shareholders' Equity
22 70 64 62 58 57 56 51
Total Liabilities
6.11 54 54 57 63 66 69 74
Total Current Liabilities
6.11 29 29 30 36 39 64 72
Short-Term Debt
3.35 13 5.80 5.72 - 0.00 10 5.21
Accounts Payable
- 7.24 6.86 8.60 13 14 14 17
Other Current Liabilities
0.06 8.45 16 16 23 25 40 49
Total Noncurrent Liabilities
0.00 25 25 27 27 27 5.13 1.80
Capital Lease Obligations
- 1.53 - - 0.98 0.83 0.67 0.31
Noncurrent Deferred & Payable Income Tax Liabilities
- 1.57 1.57 1.57 1.46 1.46 1.46 1.38
Other Noncurrent Operating Liabilities
- 0.04 1.46 1.33 0.00 0.00 0.00 0.11
Total Equity & Noncontrolling Interests
-6.02 16 9.90 5.07 -4.83 -9.17 -13 -23
Total Preferred & Common Equity
-6.02 16 9.90 5.07 -4.83 -9.17 -13 -23
Total Common Equity
-6.02 16 9.90 5.07 -4.83 -9.17 -13 -23
Common Stock
0.00 90 90 90 90 90 90 91
Retained Earnings
-6.02 -74 -80 -85 -95 -100 -103 -113

Annual Metrics And Ratios for Oxus Acquisition

This table displays calculated financial ratios and metrics derived from Oxus Acquisition's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
21,862,500.00 6,561,968.00 - 21,378,890.00
DEI Adjusted Shares Outstanding
21,862,500.00 6,561,968.00 - 21,378,890.00
DEI Earnings Per Adjusted Shares Outstanding
-0.01 -4.19 - -1.03
Growth Metrics
- - - -
Revenue Growth
0.00% 0.00% -7.72% 8.43%
EBITDA Growth
0.00% -471.14% -7.80% 26.74%
EBIT Growth
0.00% -611.78% 0.67% 25.13%
NOPAT Growth
0.00% -591.09% -2.28% 45.92%
Net Income Growth
0.00% -8,982.73% 7.83% 25.07%
EPS Growth
0.00% 0.00% 51.17% 28.80%
Operating Cash Flow Growth
0.00% -755.06% 16.19% 56.27%
Free Cash Flow Firm Growth
0.00% 0.00% -106.19% 933.86%
Invested Capital Growth
0.00% -80.01% -17.85% -152.72%
Revenue Q/Q Growth
0.00% -4.22% 1,546.27% 187.60%
EBITDA Q/Q Growth
0.00% 6.15% -218.04% -48.70%
EBIT Q/Q Growth
0.00% -16.96% -265.20% -41.98%
NOPAT Q/Q Growth
0.00% -23.29% -272.41% 13.91%
Net Income Q/Q Growth
0.00% -36.99% -1,407.34% -3.51%
EPS Q/Q Growth
0.00% 0.00% 0.00% 10.10%
Operating Cash Flow Q/Q Growth
0.00% -2.92% -2,625.97% -44.09%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 57.69% 26.04%
Invested Capital Q/Q Growth
0.00% 89.13% -13.45% -1,874.43%
Profitability Metrics
- - - -
Gross Margin
0.00% -4.35% 7.91% 5.70%
EBITDA Margin
0.00% -54.96% -64.21% -27.16%
Operating Margin
0.00% -66.53% -73.75% -17.93%
EBIT Margin
0.00% -68.50% -73.73% -30.97%
Profit (Net Income) Margin
0.00% -91.64% -91.54% -30.83%
Tax Burden Percent
100.00% 98.79% 99.47% 99.65%
Interest Burden Percent
10.48% 135.43% 124.81% 99.92%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -13.09% -44.14% -131.39%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -59.94% -69.60% -202.42%
Return on Net Nonoperating Assets (RNNOA)
0.00% -22.23% 273.94% 321.88%
Return on Equity (ROE)
-0.17% -35.32% 229.80% 190.49%
Cash Return on Invested Capital (CROIC)
0.00% 120.28% -24.55% 0.00%
Operating Return on Assets (OROA)
0.00% -16.75% -32.44% -33.86%
Return on Assets (ROA)
0.00% -22.41% -40.27% -33.72%
Return on Common Equity (ROCE)
0.00% 5.21% 229.80% 190.49%
Return on Equity Simple (ROE_SIMPLE)
19.10% 128.72% 3,639.56% 0.00%
Net Operating Profit after Tax (NOPAT)
-2.02 -14 -14 -7.73
NOPAT Margin
0.00% -46.57% -51.62% -12.55%
Net Nonoperating Expense Percent (NNEP)
-209.73% 46.85% 25.46% 71.03%
Return On Investment Capital (ROIC_SIMPLE)
- -32.37% -47.87% 59.20%
Cost of Revenue to Revenue
0.00% 104.35% 92.09% 83.33%
SG&A Expenses to Revenue
0.00% 62.18% 81.66% 23.63%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 62.18% 81.66% 29.89%
Earnings before Interest and Taxes (EBIT)
-2.89 -21 -20 -19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-2.89 -16 -18 -17
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 2.48 4.61 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.28 3.69 5.39 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 4.37 5.69 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 1.02 0.00 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.01 -3.02 -43.88 -0.32
Long-Term Debt to Equity
0.00 -0.77 -36.04 -0.03
Financial Leverage
0.00 0.37 -3.94 -1.59
Leverage Ratio
1.01 1.58 -5.71 -5.65
Compound Leverage Factor
0.11 2.13 -7.12 -5.65
Debt to Total Capital
0.84% 149.48% 102.33% -47.36%
Short-Term Debt to Total Capital
0.84% 111.21% 18.29% -43.61%
Long-Term Debt to Total Capital
0.00% 38.27% 84.04% -3.75%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
100.05% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-0.89% -49.48% -2.33% 147.36%
Debt to EBITDA
-0.52 -3.91 -1.72 -0.37
Net Debt to EBITDA
-0.28 -3.45 -1.68 -0.37
Long-Term Debt to EBITDA
0.00 -1.00 -1.41 -0.03
Debt to NOPAT
-0.74 -4.62 -2.14 -0.80
Net Debt to NOPAT
-0.41 -4.07 -2.09 -0.79
Long-Term Debt to NOPAT
0.00 -1.18 -1.76 -0.06
Altman Z-Score
54.10 -2.37 -1.79 0.00
Noncontrolling Interest Sharing Ratio
100.08% 114.74% 0.00% 0.00%
Liquidity Ratios
- - - -
Current Ratio
0.37 0.26 0.46 0.12
Quick Ratio
0.27 0.14 0.10 0.04
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 128 -7.94 30
Operating Cash Flow to CapEx
0.00% -403.15% -913.74% -10,038.06%
Free Cash Flow to Firm to Interest Expense
0.00 17.63 -1.57 5.06
Operating Cash Flow to Interest Expense
0.00 -2.47 -2.98 -1.10
Operating Cash Flow Less CapEx to Interest Expense
0.00 -3.09 -3.31 -1.11
Efficiency Ratios
- - - -
Asset Turnover
0.00 0.24 0.44 1.09
Accounts Receivable Turnover
0.00 0.00 14.79 26.68
Inventory Turnover
0.00 0.00 3.40 8.12
Fixed Asset Turnover
0.00 0.00 0.00 1.37
Accounts Payable Turnover
0.00 0.00 2.27 3.72
Days Sales Outstanding (DSO)
0.00 0.00 24.68 13.68
Days Inventory Outstanding (DIO)
0.00 0.00 107.38 44.93
Days Payable Outstanding (DPO)
0.00 0.00 160.57 98.11
Cash Conversion Cycle (CCC)
0.00 0.00 -28.51 -39.50
Capital & Investment Metrics
- - - -
Invested Capital
178 36 29 -13
Invested Capital Turnover
0.00 0.28 0.86 10.47
Increase / (Decrease) in Invested Capital
0.00 -142 -6.34 -38
Enterprise Value (EV)
405 131 157 0.00
Market Capitalization
226 74 127 0.00
Book Value per Share
($0.07) ($3.25) ($0.03) ($0.90)
Tangible Book Value per Share
($0.07) ($3.55) ($0.14) ($0.91)
Total Capital
178 43 30 -13
Total Debt
1.50 64 31 6.18
Total Long-Term Debt
0.00 17 25 0.49
Net Debt
0.82 57 30 6.12
Capital Expenditures (CapEx)
0.00 4.47 1.65 0.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.77 -9.76 -8.80 -56
Debt-free Net Working Capital (DFNWC)
-0.08 -2.14 -8.15 -56
Net Working Capital (NWC)
-1.58 -50 -14 -62
Net Nonoperating Expense (NNE)
-1.72 14 11 11
Net Nonoperating Obligations (NNO)
0.82 57 30 6.12
Total Depreciation and Amortization (D&A)
0.00 4.06 2.63 2.34
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -32.54% -31.82% -91.19%
Debt-free Net Working Capital to Revenue
0.00% -7.14% -29.46% -91.09%
Net Working Capital to Revenue
0.00% -167.16% -49.18% -100.34%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
($0.02) ($0.64) ($1.25) ($0.89)
Adjusted Weighted Average Basic Shares Outstanding
21.86M 9.08M 20.31M 21.43M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($1.25) ($0.89)
Adjusted Weighted Average Diluted Shares Outstanding
6.56M 21.38M 20.31M 21.43M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
6.56M 21.38M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-2.02 -14 -14 -6.32
Normalized NOPAT Margin
0.00% -46.57% -51.62% -10.27%
Pre Tax Income Margin
0.00% -92.76% -92.02% -30.94%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.00 -2.82 -4.03 -3.18
NOPAT to Interest Expense
0.00 -1.92 -2.82 -1.29
EBIT Less CapEx to Interest Expense
0.00 -3.44 -4.36 -3.20
NOPAT Less CapEx to Interest Expense
0.00 -2.53 -3.15 -1.30
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Oxus Acquisition

This table displays calculated financial ratios and metrics derived from Oxus Acquisition's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
6,561,968.00 6,561,968.00 6,561,968.00 6,561,968.00 21,378,852.00 - 21,378,890.00 21,378,890.00 21,378,890.00 21,378,890.00 21,378,890.00
DEI Adjusted Shares Outstanding
6,561,968.00 6,561,968.00 6,561,968.00 6,561,968.00 21,378,852.00 - 21,378,890.00 21,378,890.00 21,378,890.00 21,378,890.00 21,378,890.00
DEI Earnings Per Adjusted Shares Outstanding
-1.00 -0.79 -1.47 -1.13 -0.22 - -0.20 -0.29 -0.20 -0.34 -0.16
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% -7.84% 58.92% 99.03% -30.51% -56.65% -35.50% -5.91% 71.97% 7.63%
EBITDA Growth
-231.21% -248.95% -47.98% -5.81% -26.84% 0.91% 67.78% 30.22% 24.49% -7.79% 29.31%
EBIT Growth
-331.24% -393.00% -42.05% 2.62% -9.40% 15.40% 65.27% 26.93% 21.77% -9.79% 29.57%
NOPAT Growth
-326.30% -323.51% -52.78% 19.52% 18.13% -2.39% 58.17% 35.33% 46.84% 38.59% 29.34%
Net Income Growth
-2,797.66% -971.92% -42.05% 24.14% 26.62% 13.38% 50.33% 26.96% 21.76% -11.18% 16.12%
EPS Growth
0.00% 0.00% 10.91% 137.66% 62.30% 61.90% 59.18% -27.59% 21.74% 12.20% 20.00%
Operating Cash Flow Growth
-1,695.92% -35.50% -14.45% 20.03% 32.59% 57.97% 79.72% 48.11% 94.17% -246.43% 91.05%
Free Cash Flow Firm Growth
31,540.80% 0.00% -62.57% -114.09% -111.36% -97.77% 166.61% 173.65% 281.06% 385.23% 69.33%
Invested Capital Growth
-89.31% -80.01% 166.54% 110.60% 79.52% -17.85% -53.43% -53.21% -97.81% -152.72% -184.62%
Revenue Q/Q Growth
19.83% -117.10% 1,295.57% -35.12% 50.07% -122.42% -55.42% -53.04% 118.94% 82.53% -72.10%
EBITDA Q/Q Growth
37.94% 22.07% -178.30% 21.39% 25.60% 15.31% 55.87% -10.86% 19.49% -78.20% 71.06%
EBIT Q/Q Growth
31.47% 15.44% -125.66% 25.53% 23.01% 12.77% 50.49% -9.28% 17.58% -71.68% 68.24%
NOPAT Q/Q Growth
31.41% -2.06% -54.48% 25.58% 30.22% -27.63% 36.88% -15.05% 42.64% -47.44% 27.37%
Net Income Q/Q Growth
20.68% -1.09% -26.67% 25.31% 23.27% -19.32% 27.37% -9.85% 17.81% -69.54% 45.20%
EPS Q/Q Growth
20.78% -3.28% 22.22% 159.18% -179.31% -4.35% 75.61% 205.00% -185.71% -300.00% 77.78%
Operating Cash Flow Q/Q Growth
8.47% 59.76% -247.18% 37.45% 22.85% 74.92% -67.51% -60.06% 91.33% -1,389.61% 95.67%
Free Cash Flow Firm Q/Q Growth
-0.62% -9.56% -123.64% 33.72% 19.84% 117.78% 195.22% -26.71% 97.07% 13.79% 3.03%
Invested Capital Q/Q Growth
14.38% 89.13% 26.15% -22.83% -2.50% -13.45% -16.09% -22.46% -95.43% -1,874.43% -34.67%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
-6.17% 0.00% 1.54% 4.12% 8.28% 0.00% 13.14% 7.79% 7.19% 4.00% 11.39%
EBITDA Margin
-43.93% 0.00% -46.61% -56.47% -28.00% 0.00% -34.64% -61.09% -22.47% -21.93% -22.75%
Operating Margin
-57.25% 0.00% -44.16% -50.65% -23.55% 0.00% -42.61% -50.79% -13.30% -10.75% -27.98%
EBIT Margin
-57.20% 0.00% -53.40% -61.29% -31.44% 0.00% -42.77% -69.43% -26.14% -24.58% -27.99%
Profit (Net Income) Margin
-85.24% 0.00% -53.40% -61.47% -31.43% 0.00% -61.17% -69.61% -26.13% -24.27% -47.67%
Tax Burden Percent
100.00% 94.99% 100.00% 100.22% 100.02% 97.47% 100.00% 100.31% 100.00% 98.76% 100.00%
Interest Burden Percent
149.03% 187.55% 100.00% 100.07% 99.94% 187.13% 143.01% 99.95% 99.98% 99.97% 170.32%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-12.90% 0.00% -28.73% -45.10% -25.17% 0.00% -43.43% -31.24% -11.57% -78.76% -757.24%
ROIC Less NNEP Spread (ROIC-NNEP)
-265.73% 0.00% -53.60% -66.69% -39.56% 0.00% -51.33% -40.24% -23.06% -106.68% -770.71%
Return on Net Nonoperating Assets (RNNOA)
-3.83% 0.00% -46.27% -62.52% -61.40% 0.00% -245.13% -2,753.93% 123.94% 169.63% 860.60%
Return on Equity (ROE)
-16.73% 0.00% -75.00% -107.62% -86.58% 0.00% -288.56% -2,785.17% 112.37% 90.87% 103.36%
Cash Return on Invested Capital (CROIC)
0.00% 120.28% -141.66% -129.12% -111.02% -24.55% 38.06% 32.47% 139.34% 0.00% 0.00%
Operating Return on Assets (OROA)
-17.96% 0.00% -33.54% -46.93% -30.18% 0.00% -31.78% -25.63% -9.47% -26.88% -31.78%
Return on Assets (ROA)
-26.77% 0.00% -33.54% -47.07% -30.17% 0.00% -45.45% -25.70% -9.46% -26.54% -54.13%
Return on Common Equity (ROCE)
0.60% 0.00% -27.91% -21.23% 4.01% 0.00% -288.56% -2,785.17% 112.37% 90.87% 103.36%
Return on Equity Simple (ROE_SIMPLE)
333.05% 0.00% -185.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.10 -3.16 -4.88 -3.63 -2.53 -3.24 -2.04 -2.35 -1.35 -1.99 -1.44
NOPAT Margin
-40.08% 0.00% -30.91% -35.45% -16.49% 0.00% -29.83% -35.55% -9.31% -7.52% -19.58%
Net Nonoperating Expense Percent (NNEP)
252.82% 12.12% 24.87% 21.60% 14.39% 5.83% 7.90% 9.00% 11.49% 27.92% 13.47%
Return On Investment Capital (ROIC_SIMPLE)
- -7.32% -9.20% -9.63% -7.36% -10.84% -9.69% -14.33% -155.24% 15.22% 8.40%
Cost of Revenue to Revenue
106.17% 0.00% 90.57% 91.85% 80.44% 0.00% 86.86% 100.99% 80.68% 81.55% 88.61%
SG&A Expenses to Revenue
44.50% 0.00% 45.69% 54.77% 31.83% 0.00% 55.76% 37.91% 20.50% 19.92% 39.36%
R&D to Revenue
2.54% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.19% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
51.08% 0.00% 52.06% 58.63% 34.83% 0.00% 55.76% 62.84% 23.63% 24.72% 39.36%
Earnings before Interest and Taxes (EBIT)
-4.42 -3.74 -8.43 -6.28 -4.83 -3.16 -2.93 -4.59 -3.78 -6.49 -2.06
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-3.39 -2.64 -7.36 -5.79 -4.30 -2.62 -2.37 -4.04 -3.25 -5.79 -1.68
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 2.37 0.00 24.12 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 2.69 0.00 42.18 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.31 2.48 1.34 0.00 3.05 4.61 2.91 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
5.18 3.69 1.50 0.00 4.48 5.39 7.90 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
3.11 4.37 2.34 0.00 3.76 5.69 3.45 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 1.02 0.00 0.00 0.00 0.00 13.19 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.22 -3.02 2.27 2.81 5.79 -43.88 -5.37 -2.79 -1.07 -0.32 -0.24
Long-Term Debt to Equity
0.00 -0.77 1.46 2.22 4.66 -36.04 -5.37 -2.79 -0.28 -0.03 -0.01
Financial Leverage
0.01 0.37 0.86 0.94 1.55 -3.94 4.78 68.44 -5.37 -1.59 -1.12
Leverage Ratio
1.04 1.58 2.76 3.22 4.06 -5.71 11.32 165.30 -15.00 -5.65 -3.97
Compound Leverage Factor
1.55 2.96 2.76 3.22 4.06 -10.68 16.19 165.22 -15.00 -5.65 -6.77
Debt to Total Capital
17.77% 149.48% 69.45% 73.75% 85.28% 102.33% 122.91% 155.95% 1,591.91% -47.36% -32.14%
Short-Term Debt to Total Capital
17.77% 111.21% 24.74% 15.38% 16.62% 18.29% 0.00% 0.00% 1,169.42% -43.61% -30.32%
Long-Term Debt to Total Capital
0.00% 38.27% 44.71% 58.36% 68.66% 84.04% 122.91% 155.95% 422.49% -3.75% -1.82%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
114.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
-31.94% -49.48% 30.55% 26.25% 14.72% -2.33% -22.91% -55.95% -1,491.91% 147.36% 132.14%
Debt to EBITDA
-0.19 -3.91 -1.95 -1.45 -1.46 -1.72 -1.45 -2.08 -1.23 -0.37 -0.34
Net Debt to EBITDA
-0.19 -3.45 -1.52 -1.29 -1.43 -1.68 -1.44 -2.06 -1.22 -0.37 -0.31
Long-Term Debt to EBITDA
0.00 -1.00 -1.26 -1.15 -1.18 -1.41 -1.45 -2.08 -0.33 -0.03 -0.02
Debt to NOPAT
-0.30 -4.62 -2.35 -1.88 -2.07 -2.14 -2.26 -2.52 -1.54 -0.80 -0.77
Net Debt to NOPAT
-0.29 -4.07 -1.83 -1.67 -2.02 -2.09 -2.25 -2.50 -1.53 -0.79 -0.71
Long-Term Debt to NOPAT
0.00 -1.18 -1.51 -1.49 -1.66 -1.76 -2.26 -2.52 -0.41 -0.06 -0.04
Altman Z-Score
7.17 -1.53 -1.15 0.00 -0.57 -0.84 -0.82 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
103.57% 0.00% 62.78% 80.27% 104.63% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.01 0.26 0.77 0.53 0.44 0.46 0.29 0.25 0.15 0.12 0.10
Quick Ratio
0.01 0.14 0.45 0.20 0.12 0.10 0.06 0.06 0.04 0.04 0.03
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
154 139 -33 -22 -17 3.11 22 16 32 36 37
Operating Cash Flow to CapEx
-732.20% -205.33% -1,388.86% -823.23% -719.68% -619.86% -5,331.75% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
70.99 79.90 -22.54 -19.84 -14.47 2.40 17.39 13.07 17.05 21.90 25.58
Operating Cash Flow to Interest Expense
-2.24 -1.12 -4.64 -3.85 -2.71 -0.63 -1.09 -1.79 -0.10 -1.73 -0.08
Operating Cash Flow Less CapEx to Interest Expense
-2.54 -1.67 -4.98 -4.32 -3.08 -0.73 -1.11 -1.77 -0.10 -1.73 -0.08
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.31 0.24 0.63 0.77 0.96 0.44 0.74 0.37 0.36 1.09 1.14
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 14.79 14.60 9.17 7.81 26.68 35.25
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 3.40 5.53 2.71 2.60 8.12 9.20
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 1.05 0.49 0.47 1.37 1.40
Accounts Payable Turnover
0.00 0.00 7.72 8.70 0.00 2.27 3.97 1.90 1.69 3.72 3.41
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 24.68 24.99 39.80 46.75 13.68 10.35
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 107.38 65.95 134.79 140.50 44.93 39.70
Days Payable Outstanding (DPO)
0.00 0.00 47.25 41.95 0.00 160.57 91.92 191.72 215.55 98.11 106.98
Cash Conversion Cycle (CCC)
0.00 0.00 -47.25 -41.95 0.00 -28.51 -0.98 -17.13 -28.30 -39.50 -56.93
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
19 36 45 35 34 29 21 16 0.74 -13 -18
Invested Capital Turnover
0.32 0.28 0.93 1.27 1.53 0.86 1.46 0.88 1.24 10.47 38.67
Increase / (Decrease) in Invested Capital
-157 -142 28 18 15 -6.34 -24 -18 -33 -38 -39
Enterprise Value (EV)
97 131 67 0.00 151 157 165 0.00 0.00 0.00 0.00
Market Capitalization
72 74 38 0.00 122 127 139 0.00 0.00 0.00 0.00
Book Value per Share
($0.92) ($3.25) $2.47 $0.46 $0.24 ($0.03) ($0.23) ($0.43) ($0.60) ($0.90) ($1.06)
Tangible Book Value per Share
($0.92) ($3.55) $2.18 $0.36 $0.14 ($0.14) ($0.33) ($0.53) ($0.71) ($0.91) ($1.07)
Total Capital
19 43 53 38 34 30 21 16 0.87 -13 -17
Total Debt
3.35 64 37 28 29 31 26 26 14 6.18 5.52
Total Long-Term Debt
0.00 17 24 22 24 25 26 26 3.67 0.49 0.31
Net Debt
3.28 57 29 25 29 30 26 25 14 6.12 5.04
Capital Expenditures (CapEx)
0.66 0.95 0.49 0.51 0.45 0.13 0.03 -0.02 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2.74 -9.76 -1.72 -11 -12 -8.80 -25 -30 -45 -56 -60
Debt-free Net Working Capital (DFNWC)
-2.67 -2.14 6.49 -7.71 -11 -8.15 -25 -29 -44 -56 -60
Net Working Capital (NWC)
-6.02 -50 -6.63 -14 -17 -14 -25 -29 -55 -62 -65
Net Nonoperating Expense (NNE)
3.49 3.50 3.55 2.67 2.30 2.53 2.15 2.25 2.43 4.42 2.07
Net Nonoperating Obligations (NNO)
3.28 57 29 25 29 30 26 25 14 6.12 5.04
Total Depreciation and Amortization (D&A)
1.02 1.09 1.07 0.49 0.53 0.54 0.56 0.55 0.53 0.70 0.39
Debt-free, Cash-free Net Working Capital to Revenue
-8.76% -32.54% -6.02% -33.40% -29.60% -31.82% -53.30% -133.12% -208.51% -91.19% -97.13%
Debt-free Net Working Capital to Revenue
-8.54% -7.14% 22.65% -23.76% -27.80% -29.46% -52.90% -132.19% -207.91% -91.09% -96.35%
Net Working Capital to Revenue
-19.24% -167.16% -23.15% -41.65% -42.08% -49.18% -52.90% -132.19% -255.33% -100.34% -104.74%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.28) ($0.63) ($0.49) ($0.29) ($0.23) ($0.24) ($0.20) $0.21 ($0.18) ($0.72) ($0.16)
Adjusted Weighted Average Basic Shares Outstanding
6.56M 10.75M 17.08M 21.38M 21.38M 20.31M 21.38M 21.41M 21.46M 21.43M 21.43M
Adjusted Diluted Earnings per Share
$0.00 ($0.63) ($0.49) ($0.29) ($0.23) ($0.24) ($0.20) $0.21 ($0.18) ($0.72) ($0.16)
Adjusted Weighted Average Diluted Shares Outstanding
6.56M 10.75M 17.08M 21.38M 21.38M 20.31M 21.38M 21.41M 21.46M 21.43M 21.43M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
6.56M 21.38M 21.38M 21.38M 21.38M 0.00 21.38M 21.38M 21.46M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)
-3.10 -3.16 -4.88 -3.63 -2.53 -3.24 -2.04 -2.35 -1.35 -1.99 -1.44
Normalized NOPAT Margin
-40.08% 0.00% -30.91% -35.45% -16.49% 0.00% -29.83% -35.55% -9.31% -7.52% -19.58%
Pre Tax Income Margin
-85.24% 0.00% -53.40% -61.33% -31.42% 0.00% -61.17% -69.40% -26.13% -24.58% -47.67%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-2.04 -2.15 -5.78 -5.71 -4.00 -2.44 -2.33 -3.74 -2.04 -3.95 -1.42
NOPAT to Interest Expense
-1.43 -1.82 -3.35 -3.31 -2.10 -2.50 -1.62 -1.91 -0.73 -1.21 -1.00
EBIT Less CapEx to Interest Expense
-2.35 -2.69 -6.11 -6.18 -4.38 -2.54 -2.35 -3.72 -2.04 -3.95 -1.42
NOPAT Less CapEx to Interest Expense
-1.73 -2.36 -3.68 -3.77 -2.48 -2.60 -1.64 -1.90 -0.73 -1.21 -1.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Borealis Foods (NASDAQ: BRLS) continues to grow revenue, but profitability and liquidity remain major concerns. Over the last four years, the company has shown meaningful top-line expansion at times, but it has not translated that growth into sustained earnings or positive operating cash flow. The balance sheet also shows heavy leverage and negative equity, which raises financial risk for retail investors.

  • Revenue has improved sharply from the weak 2023 period. In Q1 2026, revenue was $7.4 million, up from $6.8 million in Q1 2025 and far above the deeply negative/erratic revenue reported in late 2023 and early 2024 restated periods.
  • Gross profit turned positive and has generally stabilized at low but positive levels. Q1 2026 gross profit was $839 thousand, suggesting the company is at least covering direct production costs on a gross basis.
  • Operating cash flow improved materially versus the worst prior quarters. Q1 2026 operating cash flow was only a small outflow of $123 thousand, better than the multi-million-dollar outflows seen in many 2024 quarters.
  • Interest-bearing debt has been actively managed through repayments and refinancing. The company regularly repays and re-raises debt, which indicates ongoing access to financing and active liability management.
  • Quarterly revenue has been volatile. Revenue ranged from over $26.4 million in Q4 2025 to $7.4 million in Q1 2026, showing uneven demand or seasonality.
  • EPS remains negative on a GAAP basis. Q1 2026 basic and diluted EPS were both -$0.16, even after a better operating quarter than some prior periods.
  • The company carries a large inventory and receivables base relative to cash. At Q1 2026, inventories were $3.5 million and receivables were $1.7 million, while cash was only about $480 thousand.
  • BRLS remains unprofitable at the operating and net-income levels. Q1 2026 operating loss was $2.1 million and net loss was $3.5 million.
  • Interest expense is a major drag on earnings. Q1 2026 interest expense was $1.45 million, which is very large relative to gross profit and makes it harder to reach profitability.
  • The balance sheet is highly leveraged and shows negative equity. As of Q1 2026, total liabilities were $73.6 million versus total assets of $51.0 million, resulting in negative shareholders’ equity of $22.7 million.
  • Liquidity is tight. Cash and equivalents were only $480 thousand in Q1 2026, while current liabilities were $71.8 million, creating a significant short-term funding risk.
  • Working capital remains deeply negative. Current assets of $6.8 million were far below current liabilities of $71.8 million, indicating the company depends heavily on ongoing financing and vendor support.
  • The company has not yet shown a durable path to self-funded growth. Historically, BRLS has relied on debt issuance and balance-sheet support to offset operating losses and cash burn.

Bottom line: Borealis Foods has improved its revenue and gross margin profile compared with its weakest periods, but the business still looks financially fragile. Until the company can demonstrate sustained operating profitability and better liquidity, the stock is likely to remain high risk.

07/19/26 05:20 PM ETAI Generated. May Contain Errors.

Oxus Acquisition Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Oxus Acquisition's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Oxus Acquisition's net income appears to be on an upward trend, with a most recent value of -$18.98 million in 2025, rising from -$302.54 thousand in 2022. The previous period was -$25.33 million in 2024.

Oxus Acquisition's total operating income in 2025 was -$11.04 million, based on the following breakdown:
  • Total Gross Profit: $3.51 million
  • Total Operating Expenses: $18.40 million

Over the last 3 years, Oxus Acquisition's total revenue changed from $0.00 in 2022 to $61.56 million in 2025, a change of 6,155,519,900.0%.

Oxus Acquisition's total liabilities were at $71.80 million at the end of 2025, a 18.3% increase from 2024, and a 30,448.2% increase since 2021.

In the past 4 years, Oxus Acquisition's cash and equivalents has ranged from $63.86 thousand in 2025 to $7.62 million in 2023, and is currently $63.86 thousand as of their latest financial filing in 2025.

Over the last 3 years, Oxus Acquisition's book value per share changed from -0.07 in 2022 to -0.90 in 2025, a change of 1,137.8%.



Financial statements for NASDAQ:OXUS last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners